COVID-19

Navigating the impact of COVID-19 in life sciences

Turning massive challenges into meaningful change for life sciences companies, HCPs, patients and caregivers.

Overcoming challenges in the life sciences industry
Overcoming challenges in the life sciences industry
Lead with Integrity and Trust
What We Learned
What We Think
Blogs
Many life sciences companies are working and collaborating tirelessly to develop treatments for COVID-19. At the same time, they must also advance the vaccines and treatments in their pipelines that are essential for so many other health issues.

Overcoming challenges in the life sciences industry

As the life sciences industry works, invests and collaborates tirelessly to fast-track testing and treatment for COVID-19, they must also continue to advance their pipelines and rethink ways of bringing treatments to patients- people depend on it.

Empowering life sciences teams to collaborate and work remotely is paramount. In addition, managing supply chain challenges so basic materials can get to clinical trials and patients and ensuring quality and safety in manufacturing is essential.

The COVID-19 pandemic is not just a short-term crisis. It has long-lasting implications for how people work, how we will treat patients and how companies will operate and be viewed in the world. Life sciences companies can redefine their position on the world stage and set a new standard as trusted, valued partners in the healthcare community.

Lead with integrity and trust

Perhaps more than ever before, the integrity and trust in life sciences companies is on a global stage. It's a once in a generation chance to do things differently.

In this climate of crisis, your responses and actions determine both how you lead in the near-term and how you can pave the way for future progress. Leaders will seize this time to take swift action and proactively prepare the organization to continue to manage its core business while ensuring a continued focus on patient health and treating COVID-19.

As you prepare and plan your response, we'd like to share our latest thinking on how the industry could manage the human and business impact.

Leading with integrity in response to COVID-19

Leading with integrity in response to COVID-19

The actions companies take now will affect trust in the industry and progress in science. We identify four ways that may advance this objective.

READ MORE

What we learned

Accenture surveyed patients and healthcare providers (HCPs) to gauge the impact coronavirus has had on their treatments, care and operations.

60%

of patients want to use technology more for communicating with healthcare providers and managing their conditions.

44%

of patients used new devices or apps to help manage conditions remotely during COVID-19.

78%

of HCPs saw a decrease in the number of patients visiting their practice during COVID-19.

What we think

VIEW MORE ARTICLES
Is COVID-19 altering how pharma engages with HCPs?

Is COVID-19 altering how pharma engages with HCPs?

We asked 720 healthcare providers (HCPs) globally on how operations and needs changed during COVID-19 and the effects for patients and pharmas.

READ MORE
How COVID-19 has changed patient behavior

How COVID-19 has changed patient behavior

Accenture's Patient Survey sets out changes in care during coronavirus and found a major shift to virtual care.

READ MORE
Agility and innovation: MedTech COVID-19 response

Agility and innovation: MedTech COVID-19 response

MedTech companies can take swift action to help solve for the COVID-19 crisis with a mindset of agility and responsible innovation.

READ MORE
View All
VIEW MORE ARTICLES

Blogs

Our life sciences leaders weigh in on the impact COVID-19 has had across all aspects of the industry and how we can take the lessons into the new challenges ahead.

Life Sciences Blog

Welcome to 2021: The year of the vaccine?

Stuart Henderson and Andrew Meade explore what to expect in 2021 for COVID-19 vaccine supply chains and employers planning a return to the workplace.

READ MORE
Life Sciences Blog

COVID-19: Three Trends Driving Cancer Care

Mathias Ganter explains how coronavirus (COVID-19) has changed the oncologist-patient relationship for better cancer care.

READ MORE
Life Sciences Blog

COVID-19 Counterfeit Medicine: Building trust

Carly Guenther explains how manufacturers can build patient trust and ensure counterfeit COVID-19 related treatments.

READ MORE
Life Sciences Blog

COVID-19: Impact on HCPs Behavior

As the pandemic stretches on, pharma companies have realized they need to do more than just communicate product information in order to be relevant.

READ MORE
Life Sciences Blog

COVID-19: Pivot to Virtual Patient Healthcare

Brad Michel discusses how patients are adapting to coronavirus (COVID-19) and the permanent changes in their behavior.

READ MORE
Subscription Center
Stay in the Know with Our Newsletter Stay in the Know with Our Newsletter
SUBSCRIBE
ribbon theme icon